Matches in Nanopublications for { ?s ?p "[Translocation of TMPRSS2-ERG is not associated with outcome and the aggressive clinical features associated with copy number increas in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP104899.RARCOu0gD0kMH4b6uOBZW_10s8f7nI522JU0GEf5im2dI130_assertion description "[Translocation of TMPRSS2-ERG is not associated with outcome and the aggressive clinical features associated with copy number increas in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP104899.RARCOu0gD0kMH4b6uOBZW_10s8f7nI522JU0GEf5im2dI130_provenance.
- NP103617.RAnrDiBU9GLAkrRczJS0sohoVijwLPw7rdxApOwsjeoWI130_assertion description "[Translocation of TMPRSS2-ERG is not associated with outcome and the aggressive clinical features associated with copy number increas in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP103617.RAnrDiBU9GLAkrRczJS0sohoVijwLPw7rdxApOwsjeoWI130_provenance.
- NP166838.RAc2IMoWtnYtDEofT0goMhJaqhNWDYWHvfFBFar8B0wSY130_assertion description "[Translocation of TMPRSS2-ERG is not associated with outcome and the aggressive clinical features associated with copy number increas in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP166838.RAc2IMoWtnYtDEofT0goMhJaqhNWDYWHvfFBFar8B0wSY130_provenance.
- NP168118.RAz3Q1T2kLkTvjHsF_nnl7udWZ_uZcs8S9PpsrXOf16pY130_assertion description "[Translocation of TMPRSS2-ERG is not associated with outcome and the aggressive clinical features associated with copy number increas in prostate cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP168118.RAz3Q1T2kLkTvjHsF_nnl7udWZ_uZcs8S9PpsrXOf16pY130_provenance.